Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ipragliflozin (ASP1941) 是一种口服有效的,选择性的 SGLT2抑制剂,对人 SGLT2 和 SGLT1,大鼠 SGLT2 和 SGLT1,小鼠 SGLT2 和 SGLT1 的 IC50分别为 7.38 和 1876 nM,6.73 和 1166 nM,5.64 和 1380 nM。Ipragliflozin 具有抗糖尿病活性。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 329 | 现货 | ||
5 mg | ¥ 788 | 现货 | ||
10 mg | ¥ 1,280 | 现货 | ||
25 mg | ¥ 2,180 | 现货 | ||
50 mg | ¥ 3,250 | 现货 | ||
100 mg | ¥ 4,730 | 现货 | ||
200 mg | ¥ 6,760 | 现货 | ||
500 mg | ¥ 9,870 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 789 | 现货 |
产品描述 | Ipragliflozin (ASP1941) is under investigation in Type 2 Diabetes and Diabetes Mellitus, Type 2. |
靶点活性 | SGLT2:5.64 nM, SGLT2 (human):7.4 nM, SGLT2 (rat):6.73 nM |
激酶实验 | Inhibition of TNF-α synthesis: TNF-α inhibitory activity is measured in lipopolysacharide (LPS) stimulated PBMC. Pomalidomide is added to human PBMCs 1 hour prior to the addition of LPS (1 μg/mL) and incubation continued for an additional 18-20 hours. Supernatants are then harvested, and the concentration of TNF-α in the supernatants is determined by ELISA. The concentration of Pomalidomide that inhibits TNF- production by 50% (IC50) is calculated by nonlinear regression analysis. The human whole blood TNF- inhibition assay is run in a similar fashion to the PBMC assay except that heparinized fresh human whole blood is plated directly into microtiter plates. |
别名 | 伊格列净, ASP1941 |
分子量 | 404.45 |
分子式 | C21H21FO5S |
CAS No. | 761423-87-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 70 mg/mL (173.07 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.4725 mL | 12.3625 mL | 24.7249 mL | 61.8123 mL |
5 mM | 0.4945 mL | 2.4725 mL | 4.945 mL | 12.3625 mL | |
10 mM | 0.2472 mL | 1.2362 mL | 2.4725 mL | 6.1812 mL | |
20 mM | 0.1236 mL | 0.6181 mL | 1.2362 mL | 3.0906 mL | |
50 mM | 0.0494 mL | 0.2472 mL | 0.4945 mL | 1.2362 mL | |
100 mM | 0.0247 mL | 0.1236 mL | 0.2472 mL | 0.6181 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Ipragliflozin 761423-87-4 GPCR/G Protein SGLT Inhibitor 伊格列净 ASP1941 ASP 1941 Sodium-dependent glucose cotransporters inhibit ASP-1941 inhibitor